Chronic kidney disease (CKD) is estimated to affect 10–14% of global population. Kidney
fibrosis, characterized by excessive extracellular matrix deposition leading to scarring, is a …

Kidney fibrosis, characterized by excessive deposition of extracellular matrix (ECM) that
leads to tissue scarring, is the final common outcome of a wide variety of chronic kidney …

Surgical delays cannot be avoided in patients unfit for surgery at the time of admission
because of poor health status, severe comorbidities, or previous medication. Some …

Idiopathic pulmonary fibrosis (IPF) is an aggressive interstitial lung disease with a high
mortality rate. Putative drug targets in IPF have failed to translate into effective therapies at …

Chronic kidney disease is an important clinical condition beset with racial and ethnic
disparities that are associated with social inequities. Many medical schools and health …

Chronic kidney disease (CKD) is a progressive loss of renal function. The gradual decline in
kidney function leads to an accumulation of toxins normally cleared by the kidneys, resulting …

Background Despite available interventions, people with type 2 diabetes (T2D) remain at
risk of chronic kidney disease (CKD). Finerenone, a potent and selective nonsteroidal …

Diabetes and high blood pressure are the primary causes of Chronic Kidney Disease (CKD).
Glomerular Filtration Rate (GFR) and kidney damage markers are used by researchers …

Given rapid advancements in medical science, it is often challenging for the busy clinician to
remain up-to-date on the fundamental and multifaceted aspects of preventive cardiology and …

Fibrosis refers to the excessive deposition of extracellular matrix components in the
processes of wound repair or tissue regeneration after tissue damage. Fibrosis occurs in …